Fundz

NeOnc Technologies

Westlake Village, California, United States · Biotechnology, Health Care, Medical · 7 employees

NeOnc is the developer of a proprietary, patented platform technology that can potentially transport pharma-based therapeutics directly to the brain without the normal boundary restrictions imposed by the body’s Blood-Brain Barrier (BBB). Using NeOnc’s formulations, pharma companies that have limited success with their CNS therapeutics because of current delivery restrictions may be able to provid

Funding history

  • Funding Round — $10.6M — Feb 2026
  • Funding Round — $1.0M — Dec 2025
  • Series seed — $1.6M — Apr 2025
  • Funding Round — $10.0M — Mar 2025
  • Funding Round — $18.3M — Oct 2024

Recent signals

  • Mar 13, 2026: NeOnc Technologies Appoints David Choi as Chief Accounting Officer
  • Feb 09, 2026: Raised $10.6M
  • Dec 18, 2025: Raised $1.0M
  • Oct 28, 2025: SEC 8-K (5.02): On October 28, 2025, NeOnc Technologies Holdings, Inc. announced the formal appointment of His Highness Sheikh Nahyan bin Zayed Al Nahyan as the Executive Chairman of NuroMENA Holdings Ltd., the company's subsidiary in the Middle East. This appointment is significant as it indicates a strategic shift in leadership that may influence the subsidiary's direction and operations in the region. No financial amounts were disclosed in connection with this leadership change. The report highlights the company's commitment to strengthening its governance and leadership structure at a critical time for growth and expansion.
  • Oct 06, 2025: SEC 8-K (1.01): NeOnc Technologies Holdings, Inc. has entered into a $50 million strategic partnership, with the closing expected to occur no later than October 23, 2025, following the completion of necessary tax identification and regulatory approvals from the United Arab Emirates. This partnership represents a significant financial commitment aimed at enhancing the company’s operational capabilities and market presence. The announcement was made through a press release on October 6, 2025, indicating the company's strategic direction and commitment to expanding its footprint in international markets.
  • Jul 10, 2025: NeOnc Technologies Forms $50 Million Strategic Partnership with Quazar Investment to Expand in the MENA Region.
  • Jun 06, 2025: NeOnc Technologies Appoints Josh Neman as Chief Clinical Officer
  • Apr 11, 2025: Raised $1.6M in Series seed

See plans & pricing → Track NeOnc Technologies’s funding, hiring, and signals — with verified contacts — on Fundz.